Baumgartner R - Search Results

1

Brain natriuretic peptide and exercise capacity in lung fibrosis and pulmonary hypertension.

Leuchte HH, Neurohr C, Baumgartner R, Holzapfel M, Giehrl W, Vogeser M, Behr J. Leuchte HH, et al. Among authors: baumgartner r. Am J Respir Crit Care Med. 2004 Aug 15;170(4):360-5. doi: 10.1164/rccm.200308-1142OC. Epub 2004 Apr 15. Am J Respir Crit Care Med. 2004. PMID: 15087298 Clinical Trial.

2

Self-Report Daily Life Activity as a Prognostic Marker of Idiopathic Pulmonary Fibrosis.

Leuchte HH, Mernitz P, Baezner C, Baumgartner RA, von Wulffen W, Neurohr C, Behr J. Leuchte HH, et al. Respiration. 2015;90(6):460-7. doi: 10.1159/000441302. Epub 2015 Nov 27. Respiration. 2015. PMID: 26610049

3

Residual pulmonary vasodilative reserve predicts outcome in idiopathic pulmonary hypertension.

Leuchte HH, Baezner C, Baumgartner RA, Muehling O, Neurohr C, Behr J. Leuchte HH, et al. Heart. 2015 Jun;101(12):972-6. doi: 10.1136/heartjnl-2015-307529. Heart. 2015. PMID: 26015441

4

Acute hemodynamic responses to supplemental oxygen and their prognostic implications in pulmonary hypertension.

Leuchte HH, Baezner CJ, Baumgartner RA, Mernitz P, Neurohr C, Behr J. Leuchte HH, et al. Respiration. 2013;85(5):400-7. doi: 10.1159/000340009. Epub 2012 Oct 4. Respiration. 2013. PMID: 23037927

5

N-terminal pro-brain natriuretic peptide and renal insufficiency as predictors of mortality in pulmonary hypertension.

Leuchte HH, El Nounou M, Tuerpe JC, Hartmann B, Baumgartner RA, Vogeser M, Muehling O, Behr J. Leuchte HH, et al. Chest. 2007 Feb;131(2):402-9. doi: 10.1378/chest.06-1758. Chest. 2007. PMID: 17296640

6

Brain natriuretic peptide is a prognostic parameter in chronic lung disease.

Leuchte HH, Baumgartner RA, Nounou ME, Vogeser M, Neurohr C, Trautnitz M, Behr J. Leuchte HH, et al. Am J Respir Crit Care Med. 2006 Apr 1;173(7):744-50. doi: 10.1164/rccm.200510-1545OC. Epub 2006 Jan 13. Am J Respir Crit Care Med. 2006. PMID: 16415273

7

Characterization of brain natriuretic peptide in long-term follow-up of pulmonary arterial hypertension.

Leuchte HH, Holzapfel M, Baumgartner RA, Neurohr C, Vogeser M, Behr J. Leuchte HH, et al. Chest. 2005 Oct;128(4):2368-74. doi: 10.1378/chest.128.4.2368. Chest. 2005. PMID: 16236896 Clinical Trial.

8

Hemodynamic response to sildenafil, nitric oxide, and iloprost in primary pulmonary hypertension.

Leuchte HH, Schwaiblmair M, Baumgartner RA, Neurohr CF, Kolbe T, Behr J. Leuchte HH, et al. Chest. 2004 Feb;125(2):580-6. doi: 10.1378/chest.125.2.580. Chest. 2004. PMID: 14769741

9

Clinical significance of brain natriuretic peptide in primary pulmonary hypertension.

Leuchte HH, Holzapfel M, Baumgartner RA, Ding I, Neurohr C, Vogeser M, Kolbe T, Schwaiblmair M, Behr J. Leuchte HH, et al. J Am Coll Cardiol. 2004 Mar 3;43(5):764-70. doi: 10.1016/j.jacc.2003.09.051. J Am Coll Cardiol. 2004. PMID: 14998614

10

Pulmonary arterial hypertension: diagnosis with fast perfusion MR imaging and high-spatial-resolution MR angiography--preliminary experience.

Nikolaou K, Schoenberg SO, Attenberger U, Scheidler J, Dietrich O, Kuehn B, Rosa F, Huber A, Leuchte H, Baumgartner R, Behr J, Reiser MF. Nikolaou K, et al. Among authors: baumgartner r. Radiology. 2005 Aug;236(2):694-703. doi: 10.1148/radiol.2361040502. Epub 2005 Jul 1. Radiology. 2005. PMID: 15994997

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results